Background {#Sec1}
==========

Wound infection is an important cause of poor wound healing and its treatment often requires the use of antibiotics \[[@CR1], [@CR2]\]. However, excessive use of antibiotics may lead to the development of antibiotic-resistant bacteria, and may also cause side effects on human health, such as gastrointestinal disturbances. In recent years, developments in nanomaterial technology have provided an opportunity to develop novel antimicrobial agents. Due to the diversity in mechanisms of action against bacteria, bacterial cells are less likely to develop antibacterial resistance compared to existing antibiotics \[[@CR3]--[@CR5]\]. However, most of these nanomaterials have application limitations, such as cytotoxicity, not biocompatible for human use, and environmental concerns.

Nanozymes are nanomaterials that catalyze the same reactions originally catalyzed by natural enzymes in biological systems \[[@CR6]--[@CR8]\]. Over the past several years, a wide variety of nanomaterials, such as noble metals \[[@CR9]--[@CR11]\], metal oxides \[[@CR12]--[@CR14]\], and carbon nanomaterials \[[@CR15]--[@CR18]\], have been explored as potential nanozymes. Based on their intrinsic enzyme-like activity, several nanozymes have been used in antibacterial applications \[[@CR19]--[@CR23]\]. For instance, platinum nanomaterials have shown effective antibacterial activity in the presence of hydrogen peroxide (H~2~O~2~) \[[@CR24]\]. The antibacterial activity of these nanozymes are attributed primarily to their oxidase- and peroxidase-like activities that catalyze the production of hydroxyl radicals (·OH) in the presence of exogenous H~2~O~2~ and enhance the cellular levels of reactive oxygen species (ROS) within bacteria cells. Fang et al. also showed that palladium nanomaterials with oxidase- and peroxidase-like activities displayed effective antibacterial activity in the presence of H~2~O~2~ \[[@CR25]\]. Although many reported enzyme-like nanomaterials have been proposed as novel antibacterial agents, the high price and persistence in living tissues are still important issues. Moreover, the application of H~2~O~2~ in human wound disinfection is harmful to healthy tissue and may delay wound healing \[[@CR26]\].

Terbium oxide nanoparticles (Tb~4~O~7~ NPs) have been extensively used as precursors for the synthesis of lanthanide nanophosphors and superconductor materials \[[@CR27], [@CR28]\]. For example, Tb~4~O~7~ complexed with reduced graphene oxide composite exhibit typical green emission of terbium ions as well as the blue self-luminescence of graphene \[[@CR28]\]. In addition, it has been found that Tb~4~O~7~ NPs can be used as analytical reagents for food analysis \[[@CR29]\]. Compared with noble metal nanomaterials, Tb~4~O~7~ NPs are easier to synthesize and are less expensive. However, a review of scientific literature was unable to find any studies that described the enzyme-like activity of Tb~4~O~7~ NPs and their applications as antibacterial agents. In this paper, we show that Tb~4~O~7~ NPs have an intrinsic oxidase-like activity at acidic pH values, as they quickly oxidize a series of organic substrates in the absence of H~2~O~2~. We then demonstrate the relationship between the oxidase-like property of Tb~4~O~7~ NPs and their antibacterial activity with in vitro studies. Finally, the effects of Tb~4~O~7~ NPs on wound disinfection and healing are evaluated in in vivo studies using a wound infection mouse model.

Materials and methods {#Sec2}
=====================

Chemicals and materials {#Sec3}
-----------------------

Tb~4~O~7~ NPs were purchased from US Research Nanomaterials, Inc. (TX, USA). 3,3,5,5-tetramethylbenzidinedihydrochloride (TMB), diammonium 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonate) (ABTS), *o*-phenylenediamine (OPD), and Lipid Peroxidation MDA Assay Kit were all purchased from Sigma-Aldrich (St. Louis, MO). The Live/Dead BacLight bacterial viability kit and 2′,7′-dichlorodihydrofluorescein diacetate (DCFH-DA) were obtained from Thermo Fisher Scientific, Inc. (MA, USA). 5-tert-butoxycarbonyl-5-methyl-1-pyrroline-*N*-oxide (BMPO) and Cell Counting Kit-8 (CCK-8) were obtained from Dojindo Laboratories (Kumamoto, Japan). *Escherichia coli* (*E. coli*) and *Staphylococcus aureus* subsp. *aureus* (*S. aureus*) were obtained from the China General Microbiological Culture Collection Center (CGMCC, Beijing, China). Human umbilical vein endothelial cells (HUVECs) were purchased from the American Type Culture Collection (ATCC, MD, USA).

Characterization of Tb~4~O~7~ NPs {#Sec4}
---------------------------------

The hydrodynamic size and zeta potential of the Tb~4~O~7~ NPs were measured using a Zetasizer Nano-ZS (Malvern, UK). The morphology and size of the Tb~4~O~7~ NPs were characterized using a transmission electron microscopy (TEM, Tecnai G-20, FEI). The UV--vis absorption spectrum was recorded on a spectrophotometer (UV-3600, Shimadzu).

Electron spin resonance spectroscopic measurements {#Sec5}
--------------------------------------------------

The electron spin resonance (ESR) measurements were carried out using a Bruker EMX ESR spectrometer according to our previous study \[[@CR3], [@CR9]\]. The final concentration of each component is described in each figure caption. All the ESR measurements were carried out at ambient temperature.

Measurement of intracellular ROS {#Sec6}
--------------------------------

After Tb~4~O~7~ NPs (100 μg/mL) treatment, bacteria (1 × 10^9^ CFU/mL) were collected by centrifugation and incubated with DCFH-DA (10 µM) for 30 min at dark, and stained bacteria were visualized with a confocal laser microscopy.

Cytotoxicity experiments {#Sec7}
------------------------

HUVECs were employed for investigating the cytotoxicity of Tb~4~O~7~ NPs. HUVECs were seeded at a density of 1 × 10^5^ cells/well in 96-well plates and incubated overnight. The HUVECs were then incubated with Tb~4~O~7~ NPs (0--100 μg/mL) for 24 h, and cell viability was measured by MTT assay.

Mice injury model {#Sec8}
-----------------

BALB/c mice (8 weeks) were purchased from Pengsheng. On the day 0, the mice were anesthetized using 10% chloral hydrate. Then, the dorsal hair of mouse was shaved, full-thickness skin wounds with the diameter of 10 mm were created on the back of each mouse. After 24 h (day 1), the mice were treated with 50 μL PBS or Tb~4~O~7~ NPs (100 μg/mL). The Tb~4~O~7~ NPs were dripping on the surface of the wound.

Hemolysis test {#Sec9}
--------------

Fresh blood was collected under sterile conditions from healthy BALB/c mice (n = 5) into an anticoagulation tube. The red blood cells were precipitated by centrifugation at 2000 rpm for 10 min and washed three times with PBS buffer solution to obtain red blood cells. The appropriate amount of red blood cells was diluted five times with PBS buffer solution to prepare a red blood cell solution. 20 μL of the diluted red blood cell suspension was mixed with a series of different concentrations of Tb~4~O~7~ NPs (0--200 μg/mL); ultrapure water was used as control. All the above samples were incubated at 37 °C for 2 h, centrifuged at 2000 rpm for 10 min, imaged, and the supernatant after centrifugation was taken in a 96-well plate to measure the absorbance at 540 nm using a microplate reader. The hemolysis rate was calculated as follows:$$\documentclass[12pt]{minimal}
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Results and discussion {#Sec10}
======================

Characterization of Tb~4~O~7~ NPs {#Sec11}
---------------------------------

The Tb~4~O~7~ NPs used in the present study were purchased from US Research Nanomaterials, Inc. The physical characterization of Tb~4~O~7~ NPs is shown in Additional file [1](#MOESM1){ref-type="media"}: Figure S1 and included images of particle core size and shape captured by TEM, the mean and homogeneity of particle hydrodynamic size by dynamic light scattering (DLS), and particle absorption spectrum by UV--vis. According to TEM and DLS data, the dispersity of Tb~4~O~7~ NPs is poor. The mean core particle size of Tb~4~O~7~ NPs is approximately 200 nm (Additional file [1](#MOESM1){ref-type="media"}: Figure S1a, b); while the DLS result of Tb~4~O~7~ NPs is around 400 nm (Additional file [1](#MOESM1){ref-type="media"}: Figure S1c). This is mainly due to the size measured by DLS was a hydrodynamic size, and therefore the nanoparticles showed a larger hydrodynamic volume due to solvent effect in the hydrated state. The zeta potential value of Tb~4~O~7~ NPs is 31.6 mV in water. The UV--vis spectrum of Tb~4~O~7~ NPs is shown in Additional file [1](#MOESM1){ref-type="media"}: Figure S1d.

Catalytic activity of Tb~4~O~7~ NPs as oxidase mimetics {#Sec12}
-------------------------------------------------------

The oxidase-like activity of Tb~4~O~7~ NPs was evaluated using the substrate TMB. The UV--vis spectroscopy measurements show time-dependent increases in TMB oxidation catalyzed by Tb~4~O~7~ NPs, yielding a blue-colored product (Fig. [1](#Fig1){ref-type="fig"}a, b). In addition, Tb~4~O~7~ NPs can also catalyze the oxidation of ABTS and OPD (Fig. [1](#Fig1){ref-type="fig"}a).Fig. 1Oxidase-like activity of Tb~4~O~7~ NPs. **a** A photograph showing the capability of the Tb~4~O~7~ NPs in catalyzing the oxidations of TMB, ABTS, and OPD that produce colored products. **b** Time-dependent absorption spectra of TMB catalyzed by Tb~4~O~7~ NPs. **c** Absorbance at 652 nm measured from samples containing TMB and different concentrations of Tb~4~O~7~ NPs. **d** The specific activities of Tb~4~O~7~ NPs. Steady-state kinetic assays of Tb~4~O~7~ NPs (**e**, **f**). **e** TMB concentration dependence of initial reaction velocity. **f** Double-reciprocal plot generated from (**d**)

We used the oxidation of TMB as a model reaction and found that the catalytic efficiency of the Tb~4~O~7~ NPs is dependent on TMB concentrations, pH and temperature (Fig. [1](#Fig1){ref-type="fig"}c and Additional file [1](#MOESM1){ref-type="media"}: Figure S2). As shown in Additional file [1](#MOESM1){ref-type="media"}: Figure S2a, Tb~4~O~7~ NPs exhibit excellent catalytic activity over a broad temperature range (25--60 °C). Moreover, an acidic condition (pH = 3.6) is conducive to the oxidase-like activity of Tb~4~O~7~ NPs (Additional file [1](#MOESM1){ref-type="media"}: Figure S2b). We adopted pH 3.6 and 25 °C (room temperature) as the standard conditions for subsequent studies.

Next, we determined the apparent steady-state kinetic parameters for the reaction of Tb~4~O~7~ NPs with TMB. Typical Michaelis--Menten curves were established (Fig. [1](#Fig1){ref-type="fig"}d). The curves were then fitted to the double-reciprocal Lineweaver--Burk plots (Fig. [1](#Fig1){ref-type="fig"}e), from which the kinetic parameters shown in Table [1](#Tab1){ref-type="table"} were determined.Table 1The kinetic constants of Tb~4~O~7~ NPs\[E\] (M)*K*~m~ (M)*V*~max~ (M/s)*K*~cat~ (s^−1^)*K*~cat~/*K*~m~ (M^−1^ S^−1^)Tb~4~O~7~ NPs7.04 × 10^−10^1.24 × 10^−4^4.31 × 10^−8^1.61 × 10^−4^1.30\[E\] is the concentration of Tb~4~O~7~ NPs. The particle number of Tb~4~O~7~ NPs is calculated using the density and diameter of Tb~4~O~7~ NPs. Dividing the particle number by the Avogadro constant is the molar concentration of Tb~4~O~7~ NPs

Effects of Tb~4~O~7~ NPs on the anti-oxidant defense system {#Sec13}
-----------------------------------------------------------

The above results show that Tb~4~O~7~ NPs have oxidase-like activity oxidizing TMB, ABTS, and OPD in the absence of H~2~O~2~. We predict that Tb~4~O~7~ NPs would deplete intracellular antioxidants and, eventually, disrupt the antioxidant defense systems of bacteria. To test this hypothesis, we examined the effects of Tb~4~O~7~ NPs on ascorbic acid (AA) oxidation in vitro. AA is an important endogenous bacterial antioxidant that prevents cellular damage from ROS. AA can be oxidized to form an intermediate ascorbyl radical (·AA), which is detectable by ESR spectroscopy \[[@CR9]\]. As shown in Fig. [2](#Fig2){ref-type="fig"}a, the oxidation of AA was negligible within 10 min, while in the presence of Tb~4~O~7~ NPs the system showed a time-dependent increase in the ESR signal intensity in the first 8 min and then decreased over time. These results indicate that Tb~4~O~7~ NPs can accelerate AA oxidation.Fig. 2**a** Oxidation of AA by Tb~4~O~7~ NPs. **b** ESR spectra of BMPO/·OH generated from a sample solution containing 25 mM BMPO, 1 mM H~2~O~2~ in the absence (control) and presence of different concentrations of Tb~4~O~7~ NPs

In the substrate oxidation mechanism of most oxidases in nature, oxygen acts as the electron acceptor and is reduced to H~2~O~2~. To gain a better understanding of the oxidation of AA by Tb~4~O~7~ NPs, we examined whether the catalytic oxidation product of Tb~4~O~7~ NPs and AA produced H~2~O~2~. As shown in Additional file [1](#MOESM1){ref-type="media"}: Figure S3, a marked increase of H~2~O~2~ was detected in the presence of Tb~4~O~7~ compared to control (AA alone). Moreover, the production of H~2~O~2~ was Tb~4~O~7~ concentration-dependent.

Previous studies have demonstrated that several kinds of nanoparticles are capable of catalyzing the production of hydroxyl radicals by H~2~O~2~ \[[@CR30], [@CR31]\]. Therefore, we determined whether Tb~4~O~7~ NPs would catalyze the production of hydroxyl radicals by H~2~O~2~ using ESR spectroscopy. We selected BMPO as the capture agent, since BMPO can capture hydroxyl radicals to form BMPO/·OH adducts indicated by the presence of four characteristic lines on the ESR spectrum. As shown in Fig. [2](#Fig2){ref-type="fig"}b, the characteristic ESR signals of BMPO/·OH were negligible in the absence of Tb~4~O~7~ NPs. However, the addition of Tb~4~O~7~ NPs resulted in a strong ESR spectrum that displayed the four characteristic lines (1:2:2:1) of BMPO/·OH. These results clearly show that Tb~4~O~7~ NPs can be used as a catalyst in the decomposition of H~2~O~2~ to produce hydroxyl radicals.

Taken together, our results confirm that Tb~4~O~7~ NPs are capable of catalyzing the oxidation of biologically relevant antioxidant agents, resulting in the production of H~2~O~2~. Moreover, Tb~4~O~7~ NPs can further catalyze the production of hydroxyl radicals via the decomposition of H~2~O~2~.

Antibacterial activity of Tb~4~O~7~ NPs {#Sec14}
---------------------------------------

Both H~2~O~2~ and hydroxyl radicals have strong oxidizing ability and can oxidize biological macromolecules, such as proteins and phospholipids \[[@CR32]\]. Our study found that Tb~4~O~7~ NPs with oxidase-like activity can catalyze the production of H~2~O~2~ and further produce hydroxyl radicals. Therefore, the oxidase-like activity of the Tb~4~O~7~ NPs makes them potentially useful as antibacterial agents. We evaluated the antibacterial activity of Tb~4~O~7~ NPs against *E. coli* and *S. aureus*. A colony-forming units plate counting method was used to determine the antibacterial ability (Fig. [3](#Fig3){ref-type="fig"}a, b). As compared to the PBS control group, Tb~4~O~7~ NPs exhibited potent antimicrobial activity against both *S. aureus* and *E. coli* in a concentration-dependent manner. At a concentration of 25 μg/mL, Tb~4~O~7~ NPs exhibited only modest antibacterial effects against *S. aureus*; more than 80% of the bacterial cells survived. However, when the concentration of Tb~4~O~7~ NPs was increased to 100 μg/mL, nearly 90% of the *S. aureus* were killed. A similar trend of antibacterial effects were observed towards the *E. coli*.Fig. 3The effect of Tb~4~O~7~ NPs on survival rates of bacteria **a** CFUs of *S. aureus* following incubation with Tb~4~O~7~ NPs; **b** CFUs of *E. coli* following incubation with Tb~4~O~7~ NPs; **c** Representative fluorescence and SEM images of *S. aureus* after Tb~4~O~7~ NPs treatments. Bacterial cells were treated with 1) PBS as control, 2) 25 μg/mL Tb~4~O~7~ NPs, 3) 50 μg/mL Tb~4~O~7~ NPs or 4) 100 μg/mL Tb~4~O~7~ NPs; **d** Representative fluorescence and SEM images of *E. coli* after Tb~4~O~7~ NPs treatments. Bacterial cells were treated with 1) PBS as control, 2) 10 μg/mL Tb~4~O~7~ NPs, 3) 25 μg/mL Tb~4~O~7~ NPs or 4) 50 μg/mL Tb~4~O~7~ NPs. \*\**p* \< 0.01 and \*\*\**p* \< 0.001 vs control

To further investigate the interaction between Tb~4~O~7~ NPs and bacteria, a fluorescent-based cell live/dead assay was conducted. As shown in Fig. [3](#Fig3){ref-type="fig"}c, d, Tb~4~O~7~ NPs exhibited significant antibacterial activity against both *S. aureus* and *E. coli*, which was consistent with the aforementioned results. The exposure of *S. aureus* cells to Tb~4~O~7~ NPs at a concentration of 100 μg/mL resulted in nearly 100% lethality, as evidenced by the dominant red fluorescent signal. At a concentration of 50 μg/mL, Tb~4~O~7~ NPs completely inhibited the bacterial growth of *E. coli*.

The morphology and membrane integrity of bacteria were then determined by SEM (Fig. [3](#Fig3){ref-type="fig"}c, d). Untreated *S. aureus* displayed a typical rod-shaped structure with a continuous, smooth surface. When exposure to the 50 μg/mL of Tb~4~O~7~ NPs, the *S. aureus* bacterial cell walls became partially wrinkled and discontinuance. Notably, after treatment with 100 μg/mL of Tb~4~O~7~ NPs, the *S. aureus* bacterial cell walls showed much more pronounced damage, indicating stronger antibacterial effects at higher concentrations of Tb~4~O~7~ NPs. A similar tendency was found for *E. coli*. The loss of membrane integrity of *E. coli* was observed at concentrations lower than 100 μg/mL of Tb~4~O~7~ NPs treatment. Moreover, Tb~4~O~7~ NPs were observed by SEM and SEM-energy dispersive X-ray spectroscopy (EDS) to aggregate on the surfaces of *S. aureus* and *E. coli* (Additional file [1](#MOESM1){ref-type="media"}: Figure S4).

It is known that the proton motive force decreases the local pH (as low as pH 3.0) in the cytoplasm and membrane of bacteria cells \[[@CR33], [@CR34]\]. Since we found that Tb~4~O~7~ NPs exhibit oxidase-like activity under acidic conditions, we speculate that the antibacterial mechanism of Tb~4~O~7~ NPs may arise from their oxidase activity to accelerate the process of bacterial cell oxidation and consumption of antioxidant biomolecules, leading to a reduction of oxygen products including H~2~O~2~ along with other antibacterial activity from the accumulation of ROS. To confirm this hypothesis, the intracellular levels of ROS were determined using the florescent probe, DCFH-DA (Fig. [4](#Fig4){ref-type="fig"}). For both *S. aureus* and *E. coli*, the untreated cells showed extremely weak fluorescence, indicating low levels in the formation of intracellular ROS. In contrast, bacterial cells exposed to Tb~4~O~7~ NPs showed high levels of ROS formed within the cellular cytoplasm, as evidenced by the strong fluorescence signal. We also found that the generation of ROS is Tb~4~O~7~ NPs dose-dependent (Additional file [1](#MOESM1){ref-type="media"}: Figure S5).Fig. 4**a** Fluorescence images of bacterial cells. **b** Analysis of the ROS levels by microplate reader. \*\*\**p* \< 0.001 vs control

In vivo wound disinfection effect of Tb~4~O~7~ NPs {#Sec15}
--------------------------------------------------

The above findings suggest that Tb~4~O~7~ NPs may have role as an antibacterial agent for bacterial infections in vivo. To assess the antibacterial capacity of Tb~4~O~7~ NPs in vivo, a wound infection model was constructed using BALB/c mice. A wound was introduced on the back of the mouse and an infection was established by implanting *S. aureus* into the wounded area. After infection was established, PBS or Tb~4~O~7~ NPs were applied to the infected wound. Figure [5](#Fig5){ref-type="fig"}a, b shows the progress of the wounds. Compared with the control (PBS treatment) group after 3 days, the wound area was reduced under Tb~4~O~7~ NPs treatment. After treating of 7 days with Tb~4~O~7~ NPs treatment, the wounds were nearly healed completely. In contrast, obvious scab was observed from the control group, indicating incomplete recovery.Fig. 5**a** Photographs of wounds on the backs of mice in control (PBS) and Tb~4~O~7~ NPs treatment groups (n = 5). Scale bar: 5 mm. **b** Related wound size in each treatment group. **c** Bacterial number of infected wounds on the 7th day. \*\*\**p* \< 0.001 vs control

Biosafety of Tb~4~O~7~ NPs {#Sec16}
--------------------------

Biosafety is an important factor for antimicrobial agents designers. To assess the biosafety of Tb~4~O~7~ NPs, we first determined the effects of Tb~4~O~7~ NPs on red blood cells and HUVECs in vitro. The effect of Tb~4~O~7~ NPs on cell membrane disrupt was first determined by a red blood cell hemolysis assay. As shown in Fig. [6](#Fig6){ref-type="fig"}a, pure water can cause severe red blood cells hemolysis within 2 h. In contrast, the introduction of Tb~4~O~7~ NPs did not cause signs of hemolysis. In this experimental result, the hemolysis rate was still less than 1% at a concentration of 100 µg/mL, which fully demonstrated that Tb~4~O~7~ NPs have good blood compatibility. Meanwhile, the cytotoxicity tests on mammalian cells HUVECs further confirm the biosafety of Tb~4~O~7~ NPs (Fig. [6](#Fig6){ref-type="fig"}b).Fig. 6**a** The hemolysis ratio of red blood cells. The insert images of tubes containing red blood cells solution show the direct observation of hemolysis. Tube 1: PBS buffer; Tube 2--5: 25, 50, 100, and 200 μg/mL Tb~4~O~7~ NPs; Tube 6: ultrapure water. **b** MTT assays determined cell viability of HUVECs after Tb~4~O~7~ NPs treatment

Then, the biosafety of Tb~4~O~7~ NPs in vivo were determined. As shown in Fig. [7](#Fig7){ref-type="fig"}a, the indicators in blood were within the normal range. The major mouse organs (heart, liver, spleen, lung, and kidney) were formalin-fixed and processed for the evaluation of H&E sections by histopathology (Fig. [7](#Fig7){ref-type="fig"}b). No obvious mouse organ damage was observed from Tb~4~O~7~ NPs treatment.Fig. 7In vivo toxicity of Tb~4~O~7~ NPs. **a** The blood biochemistry data of the mice treated with Tb~4~O~7~ NPs after 7 d (n = 5). **b** Histological data (H&E staining images) are obtained from the major organs of mice treated with Tb~4~O~7~ NPs after 7 d. Scale bar = 100 μm

Conclusions {#Sec17}
===========

In summary, this study demonstrates for the first time that Tb~4~O~7~ NPs exhibit oxidase-like activity. In addition, the results of this study established a relationship between the oxidase-like enzyme activity of Tb~4~O~7~ NPs and their antibacterial properties. The data collected from this work revealed that the oxidase-like activity of Tb~4~O~7~ NPs was able to function with a variety of substrates, including biomolecules, and resulted in the generation of ROS, which further enhanced their antibacterial activity. The application of the antibacterial activities of Tb~4~O~7~ NPs were demonstrated in a wound infection mouse model. Our study provides evidence that Tb~4~O~7~ NPs can be utilized as an efficient antibacterial agent and the potential applications in wound healing are promising.

Additional file
===============

 {#Sec18}

**Additional file 1: Figure S1.** Characterization of Tb~4~O~7~ NPs. **Figure S2.** The oxidase-like catalytic activity of the Tb~4~O~7~ NPs. **Figure S3.** The concentration of H~2~O~2~ generated in the catalytic system. **Figure S4.** SEM-EDS elemental images. **Figure S5.** ROS levels of *S. aureus*.
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